nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Progressive multifocal leukoencephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.117	0.134	CcSEcCtD
Nelarabine—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.0342	0.0391	CcSEcCtD
Nelarabine—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.0259	0.0297	CcSEcCtD
Nelarabine—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0248	0.0284	CcSEcCtD
Nelarabine—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0246	0.0281	CcSEcCtD
Nelarabine—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.0236	0.027	CcSEcCtD
Nelarabine—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0227	0.026	CcSEcCtD
Nelarabine—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.0204	0.0234	CcSEcCtD
Nelarabine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0193	0.0221	CcSEcCtD
Nelarabine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0182	0.0209	CcSEcCtD
Nelarabine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0204	CcSEcCtD
Nelarabine—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0173	0.0199	CcSEcCtD
Nelarabine—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0195	CcSEcCtD
Nelarabine—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0184	CcSEcCtD
Nelarabine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.017	CcSEcCtD
Nelarabine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0165	CcSEcCtD
Nelarabine—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0163	CcSEcCtD
Nelarabine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0157	CcSEcCtD
Nelarabine—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0157	CcSEcCtD
Nelarabine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0134	CcSEcCtD
Nelarabine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0134	CcSEcCtD
Nelarabine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0131	CcSEcCtD
Nelarabine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0123	CcSEcCtD
Nelarabine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0116	CcSEcCtD
Nelarabine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00996	0.0114	CcSEcCtD
Nelarabine—POLA1—Removal of the Flap Intermediate—PCNA—focal segmental glomerulosclerosis	0.00979	0.0771	CbGpPWpGaD
Nelarabine—POLA1—Leading Strand Synthesis—PCNA—focal segmental glomerulosclerosis	0.00979	0.0771	CbGpPWpGaD
Nelarabine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00893	0.0102	CcSEcCtD
Nelarabine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.0102	CcSEcCtD
Nelarabine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00883	0.0101	CcSEcCtD
Nelarabine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00883	0.0101	CcSEcCtD
Nelarabine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.0088	0.0101	CcSEcCtD
Nelarabine—POLA1—Processive synthesis on the lagging strand—PCNA—focal segmental glomerulosclerosis	0.0088	0.0693	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00865	0.00991	CcSEcCtD
Nelarabine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0086	0.00985	CcSEcCtD
Nelarabine—POLA1—G1/S-Specific Transcription—PCNA—focal segmental glomerulosclerosis	0.00838	0.066	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00835	0.00956	CcSEcCtD
Nelarabine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00832	0.00953	CcSEcCtD
Nelarabine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00828	0.00948	CcSEcCtD
Nelarabine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00788	0.00903	CcSEcCtD
Nelarabine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00782	0.00896	CcSEcCtD
Nelarabine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00779	0.00892	CcSEcCtD
Nelarabine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0089	CcSEcCtD
Nelarabine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00719	0.00823	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—WT1—focal segmental glomerulosclerosis	0.00718	0.0566	CbGpPWpGaD
Nelarabine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.00818	CcSEcCtD
Nelarabine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00711	0.00814	CcSEcCtD
Nelarabine—POLA1—Lagging Strand Synthesis—PCNA—focal segmental glomerulosclerosis	0.00708	0.0557	CbGpPWpGaD
Nelarabine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00694	0.00795	CcSEcCtD
Nelarabine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0069	0.0079	CcSEcCtD
Nelarabine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00675	0.00774	CcSEcCtD
Nelarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—focal segmental glomerulosclerosis	0.00658	0.0518	CbGpPWpGaD
Nelarabine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0065	0.00744	CcSEcCtD
Nelarabine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00646	0.0074	CcSEcCtD
Nelarabine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00637	0.0073	CcSEcCtD
Nelarabine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00617	0.00707	CcSEcCtD
Nelarabine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00602	0.00689	CcSEcCtD
Nelarabine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00598	0.00684	CcSEcCtD
Nelarabine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00587	0.00673	CcSEcCtD
Nelarabine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00587	0.00673	CcSEcCtD
Nelarabine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00587	0.00673	CcSEcCtD
Nelarabine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00568	0.0065	CcSEcCtD
Nelarabine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00563	0.00645	CcSEcCtD
Nelarabine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.0064	CcSEcCtD
Nelarabine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00552	0.00632	CcSEcCtD
Nelarabine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00551	0.00631	CcSEcCtD
Nelarabine—POLA1—Extension of Telomeres—PCNA—focal segmental glomerulosclerosis	0.00547	0.0431	CbGpPWpGaD
Nelarabine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00537	0.00615	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00513	0.00587	CcSEcCtD
Nelarabine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.00583	CcSEcCtD
Nelarabine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.00579	CcSEcCtD
Nelarabine—POLA1—DNA strand elongation—PCNA—focal segmental glomerulosclerosis	0.00505	0.0398	CbGpPWpGaD
Nelarabine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00575	CcSEcCtD
Nelarabine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.00573	CcSEcCtD
Nelarabine—POLA1—E2F mediated regulation of DNA replication—PCNA—focal segmental glomerulosclerosis	0.00493	0.0388	CbGpPWpGaD
Nelarabine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.0056	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.00557	CcSEcCtD
Nelarabine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00556	CcSEcCtD
Nelarabine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00481	0.00551	CcSEcCtD
Nelarabine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00481	0.00551	CcSEcCtD
Nelarabine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00464	0.00531	CcSEcCtD
Nelarabine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00527	CcSEcCtD
Nelarabine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.0051	CcSEcCtD
Nelarabine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.0051	CcSEcCtD
Nelarabine—POLA1—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.00406	0.032	CbGpPWpGaD
Nelarabine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.00463	CcSEcCtD
Nelarabine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00441	CcSEcCtD
Nelarabine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.00426	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00362	0.0286	CbGpPWpGaD
Nelarabine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00358	0.0041	CcSEcCtD
Nelarabine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00404	CcSEcCtD
Nelarabine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00383	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	0.0031	0.0244	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.00257	0.0202	CbGpPWpGaD
Nelarabine—POLA1—Telomere Maintenance—PCNA—focal segmental glomerulosclerosis	0.00248	0.0195	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00246	0.0194	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00239	0.0189	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	0.00227	0.0179	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—PCNA—focal segmental glomerulosclerosis	0.0021	0.0165	CbGpPWpGaD
Nelarabine—POLA1—Chromosome Maintenance—PCNA—focal segmental glomerulosclerosis	0.00206	0.0163	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—PCNA—focal segmental glomerulosclerosis	0.00197	0.0155	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—PCNA—focal segmental glomerulosclerosis	0.00189	0.0149	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.00185	0.0146	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00177	0.0139	CbGpPWpGaD
Nelarabine—POLA1—S Phase—PCNA—focal segmental glomerulosclerosis	0.00172	0.0136	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PCNA—focal segmental glomerulosclerosis	0.0016	0.0126	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00156	0.0123	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00144	0.0114	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00143	0.0113	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00122	0.00958	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00121	0.00953	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LPL—focal segmental glomerulosclerosis	0.00108	0.0085	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AGT—focal segmental glomerulosclerosis	0.000923	0.00727	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALB—focal segmental glomerulosclerosis	0.000709	0.00558	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000587	0.00463	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	0.000586	0.00461	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000542	0.00427	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.00054	0.00426	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000524	0.00413	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000517	0.00407	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000477	0.00376	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000476	0.00375	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000439	0.00346	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPL—focal segmental glomerulosclerosis	0.000358	0.00282	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPL—focal segmental glomerulosclerosis	0.000331	0.00261	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AGT—focal segmental glomerulosclerosis	0.000306	0.00241	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AGT—focal segmental glomerulosclerosis	0.000283	0.00223	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—focal segmental glomerulosclerosis	0.000235	0.00185	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—focal segmental glomerulosclerosis	0.000217	0.00171	CbGpPWpGaD
